Back to News
Market Impact: 0.34

TD Cowen cuts Procore stock price target on valuation, keeps Buy

PCOR
Analyst EstimatesAnalyst InsightsCorporate EarningsCorporate Guidance & OutlookCompany FundamentalsManagement & Governance
TD Cowen cuts Procore stock price target on valuation, keeps Buy

TD Cowen cut Procore's price target to $75 from $85 but kept a Buy rating, citing expected revenue beat, a likely increase to FY2026 guidance, and 20% remaining performance obligations growth. The stock is viewed as attractive at about 4.5x enterprise value to CY2027 estimated sales, while recent Q4 2025 results also topped expectations with EPS of $0.37 versus $0.36 consensus and revenue of $349 million versus $340.76 million. Management transitions remain a focus, with Rachel Pyles and Walt Hearn designated as CFO and CRO, respectively, by April 1, 2026.

Analysis

The setup is less about a clean acceleration and more about a quality re-rating under still-improving fundamentals. A mid-teens organic growth profile on a software multiple that is now closer to hardware-discount territory implies the market is still pricing Procore as a cyclical construction proxy rather than a mission-critical workflow platform. If guide-up follows a beat, the next leg is likely driven by multiple expansion rather than near-term EPS leverage, because management turnover usually delays margin conclusions until the new CFO/CRO establish cadence and pipeline discipline. The second-order winner is the broader construction-tech ecosystem: when Procore holds up in a flat-to-down construction spend tape, it validates budget resilience for adjacent vertical SaaS vendors and weakens the bear case that project software is merely a delayed capex beta. That said, improving bookings quality here could also pressure smaller point-solution competitors, since enterprise buyers tend to standardize after a CFO/CRO transition when renewal and expansion metrics are easiest to police. The main risk is that the market may be over-crediting stabilization before end-demand actually turns. A 20% RPO growth assumption is good, but if duration tailwind fades faster than expected, reported growth can decelerate sharply over the next 2-3 quarters even if bookings remain healthy, which would compress the multiple again. The contrast between bullish valuation commentary and scattered Street targets suggests consensus is still unsure whether this is a true reacceleration story or just a transient comping effect. The contrarian angle is that this may be an under-owned operational inflection, not a fully priced recovery. With valuation anchored to roughly 4.5x forward sales, the stock likely does not need a perfect macro backdrop—only evidence that churn is contained and net retention stabilizes through the new management regime. If that happens, the most efficient path higher is a sentiment squeeze on guided revenue and RPO, not a gradual grind.